May 16, 2013 Fans of Amgen Tour of California face daunting mission - Mcclatchy-Tribune Information Services -- Unrestricted
May 16, 2013 Gilead Drug For Leukemia Shows Success In Early Trial - Investors Business Daily
May 16, 2013 The Zacks Analyst Blog Highlights: Genomic Health, Sanofi, Regeneron Pharmaceuticals, Amgen and Isis Pharmaceuticals - Pr Newswire
May 16, 2013 Vital Therapies, Inc. Adds Two New Board Members - Marketwire
May 15, 2013 Amgen Highlights Data To Be Presented At American Society of Clinical Oncology Annual Meeting - Pr Newswire
May 15, 2013 Amgen Tour of California rolls into Santa Clarita - Mcclatchy-Tribune Information Services -- Unrestricted
May 15, 2013 Amgen Tour of California rolls into Santa Clarita - Mcclatchy-Tribune Information Services -- Unrestricted
May 15, 2013 Amgen Tour of California: Peter Sagan's ninth stage victory 'a little bit crazy' - Mcclatchy-Tribune Information Services -- Unrestricted
May 15, 2013 Amgen, Hospira and Sandoz Named Among Top Pharmaceutical Companies with Greatest Biosimilar Drug Potential in United States - M2
May 15, 2013 Cycling fans in Ojai gearing up for today's arrival of Amgen Tour - Mcclatchy-Tribune Information Services -- Unrestricted
May 15, 2013 Cycling's Peter Sagan is Tour of California sprint star - Mcclatchy-Tribune Information Services -- Unrestricted
May 15, 2013 Cycling's Peter Sagan is Tour of California sprint star - Mcclatchy-Tribune Information Services -- Unrestricted
May 15, 2013 Fans waited to cheer on Amgen Tour cyclists passing through Ventura County - Mcclatchy-Tribune Information Services -- Unrestricted
May 15, 2013 Healthcare Businesswomen's Association Southern California Chapter Honors Amgen Executive Qi Jiang as a 2013 "Rising Star" - Businesswire
May 15, 2013 Many Avila Beach businesses hope Tour of California boosts sales - Mcclatchy-Tribune Information Services -- Unrestricted
May 15, 2013 New Analyses Identify Predictive Biomarkers For VectibixA? (Panitumumab) In Patients With Metastatic Colorectal Cancer - Pr Newswire
May 15, 2013 Sanofi and Regeneron`s Latest Partnership - TheMotleyFool
May 15, 2013 Top 4 NASDAQ Stocks In The Biotechnology Industry With The Highest EPS Estimates For The Next Quarter - Benzinga
May 15, 2013 Zhejiang Beta Pharma to Form JV with Amgen - Sinocast
May 14, 2013 Amgen, Hospira and Sandoz Named Among Top Pharmaceutical Companies with Greatest Biosimilar Drug Potential in United States - Pr Newswire
May 14, 2013 Amgen, Hospira and Sandoz Named Among Top Pharmaceutical Companies with Greatest Biosimilar Drug Potential in United States - Thomson Reuters One
May 14, 2013 Buyers Accumulate Shares of Amgen, Up 1.6% - Financial News Network Online - Market Movers
May 14, 2013 Don`t Get Too Excited About This Cancer Drug Yet - TheMotleyFool
May 14, 2013 Many Avila Beach businesses hoping for increased sales during Tour of California cycling event - Mcclatchy-Tribune Information Services -- Unrestricted
May 14, 2013 Nuvilex Inc. Reminiscent of Major Biotech Success Stories - Marketwire
May 13, 2013 Bill would regulate 'biosimilar' drugs - Mcclatchy-Tribune Information Services -- Unrestricted
May 12, 2013 BRIEF: Westra sprints to win in first stage of Amgen Tour of California - Mcclatchy-Tribune Information Services -- Unrestricted
May 12, 2013 Visit Santa Rosa Announces Line-up of Festivities for 2013 Amgen Tour of California Finale - Prweb
May 11, 2013 Amgen Tour of California's decisive stages in San Jose, East Bay - Mcclatchy-Tribune Information Services -- Unrestricted
May 11, 2013 BRIEF: Amgen Tour of California starts Sunday in Escondido - Mcclatchy-Tribune Information Services -- Unrestricted
May 11, 2013 Cycling tries to put doping in the past - Mcclatchy-Tribune Information Services -- Unrestricted
May 11, 2013 Short Interest in Vertex Rises, in Celgene Falls - Benzinga
May 10, 2013 Amgen Signs Chinese Partner for Vectibix - TheMotleyFool
May 10, 2013 Amgen Tour of California's decisive stages in San Jose, East Bay - Mcclatchy-Tribune Information Services -- Unrestricted
May 10, 2013 Amgen biotech program gets high school students hands-on in STEM fields - Mcclatchy-Tribune Information Services -- Unrestricted
May 10, 2013 Amgen enters joint venture with Chinese firm - Mcclatchy-Tribune Information Services -- Unrestricted
May 10, 2013 Amgen to form joint venture with Zhejiang Beta Pharma to bring Vectibix to Chinese patients with mCRC - M2
May 10, 2013 Bacterial Partnering Terms and Agreements - 2013 Report Features Over 1,000 Links to Online Copies of Actual Bacterial Deals - M2
May 10, 2013 Dental Partnering Terms and Agreements - 2013 Contains Over 500 Links to Online Copies of Actual Dental Deals - M2
May 10, 2013 Hematology Partnering Terms and Agreements - 2013 Features Players such as Lundbeck, GlaxoSmithKline and Astellas - M2
May 10, 2013 Potential Amgen (AMGN) Trade Has $102.68 Breakeven - Freshbrewedmedia
May 10, 2013 Research and Markets Adds Report: Amgen Partnering 2005-2013 - Close-Up Media
May 10, 2013 S&P Highlights Biotech ETFs - Benzinga
May 10, 2013 The Corporate Reputation of Pharma in 2012: The Patient Perspective on 29 of the World's Leading Pharma Companies - M2
May 9, 2013 2013 Amgen Tour of California Organizers to Host Pre-Race Press Conference with Top Cyclists and Race Officials - Businesswire
May 9, 2013 Amgen And Zhejiang Beta Pharma Announce Planned Joint Venture In China - Benzinga
May 9, 2013 Amgen And Zhejiang Beta Pharma Announce Planned Joint Venture In China - Pr Newswire
May 9, 2013 Amgen And Zhejiang Beta Pharma Announce Planned Joint Venture In China - Pr Newswire Europe
May 9, 2013 Dermatology Partnering Terms and Agreements - 2013 Report - M2
May 9, 2013 Viral Partnering Terms and Agreements - 2013 Report Features Players such as AstraZeneca and Novartis - M2
May 8, 2013 Amgen Fulfills the Promise: Up 0.2% Since Last Week's Upgrade - Financial News Network Online - News Corner
May 8, 2013 BRIEF: Amgen announces results of colorectal cancer drug trial - Mcclatchy-Tribune Information Services -- Unrestricted
May 8, 2013 Dermatology Partnering Terms and Agreements - 2013 - M2
May 8, 2013 Gastrointestinal Partnering Terms and Agreements 2013: Latest Analysis from the World's Leadng Healthcare Companies - M2
May 8, 2013 Sensory Organ Partnering Terms and Agreements - M2
May 7, 2013 3 Hallmarks of a Megablockbuster - TheMotleyFool
May 7, 2013 Amgen Announces Top-Line Results of Vectibix Phase 3 Head-to-Head Study Against Erbitux in Metastatic Colorectal Cancer - Benzinga
May 7, 2013 Amgen Announces Top-Line Results of VectibixA? (panitumumab) Phase 3 Head-to-Head Study Against ErbituxA? (cetuximab) in Metastatic Colorectal Cancer - Pr Newswire
May 7, 2013 Amgen Partnering 2005-2013 - M2
May 7, 2013 Florida Won`t Protect Biotechs From Competition - YCharts
May 7, 2013 Research and Markets: Amgen Partnering 2005-2013 - Businesswire
May 7, 2013 Top 3 Companies in the Biotechnology Industry With the Highest Sales per Share (BIIB, AMGN, UTHR) - Financial News Network Online - News Corner
May 7, 2013 Tour of California: Former champion Chris Horner out with injury - Mcclatchy-Tribune Information Services -- Unrestricted
May 6, 2013 Amgen (AMGN) Approaches New Downside Target of $105.30 - Financial News Network Online - Pivot Alerts
May 6, 2013 Amgen Has Returned 17.4% Since SmarTrend Recommendation (AMGN) - Comtex Smartrend(R)
May 6, 2013 Amgen aims to restock its medicine cabinet - Mcclatchy-Tribune Information Services -- Unrestricted
May 6, 2013 Leading Biotechs Act Well But Be Careful Not To Chase - Investors Business Daily
May 6, 2013 Transgenomic in Collaboration Agreement with Amgen - Benzinga
May 3, 2013 Amgen (AMGN) Approaches New Upside Target of $108.15 - Financial News Network Online - Pivot Alerts
May 3, 2013 Amgen reports higher Q1 net income, provides outlook for 2013 - Datamonitor
May 3, 2013 Three Sector ETFs Up 20% or More YTD - Benzinga
May 2, 2013 Amgen (AMGN) Showing Resistance Near $107.81 With 1.76% Dividend Yield - Freshbrewedmedia
May 2, 2013 Amgen Reports Online Availability of Tour of California Media Credential Application - Close-Up Media
May 2, 2013 Cure Magazine Names Winner of the 2013 Extraordinary Healer Award for Oncology Nursing - Close-Up Media
May 2, 2013 Opsona Therapeutics Limited Raises Oversubscribed Series C equity Financing - Close-Up Media
May 2, 2013 Relatively Good Performance Detected in Shares of Regeneron Pharmaceuticals in the Biotechnology Industry (REGN, AMGN, VRTX, SNTA, ARNA) - Financial News Network Online - News Corner
May 2, 2013 Top Fund Buys Focus On Defensive Stocks, Housing - Investors Business Daily
May 1, 2013 AFFY, AMGN, VRTX, and QCOR Early Briefing and Review - Accesswire-Tnw
May 1, 2013 AG Gansler Secures Agreement with Drug Maker over Pricing Scheme Amgen's artificial price spread ripped off Medicaid to boost drug sales - M2
May 1, 2013 Amgen`s - Investors Business Daily
May 1, 2013 Analyst Moves: AMGN, FCX, AVP - Marketnewsvideo.Com
May 1, 2013 Analysts` Actions: AMGN BIIB DWA FCX ULTI - TheStreet.com
May 1, 2013 BRIEF: Amgen pays $11 million to settle Medicaid pricing suit - Mcclatchy-Tribune Information Services -- Unrestricted
May 1, 2013 Benzinga`s Top Upgrades - Benzinga
May 1, 2013 CURE Magazine Names Winner of the 2013 Extraordinary Healer Award for Oncology Nursing - Close-Up Media
May 1, 2013 Four Californians Selected as Breakaway from CancerA? Champions to be Honored During Amgen Tour of California - Pr Newswire
May 1, 2013 Piper Jaffray Made the Right Call, Amgen 7.6% Lower (AMGN) - Financial News Network Online - News Corner
May 1, 2013 Upgrade Alert for Amgen (AMGN) - Comtex Smartrend(R)
